The people behind the vision
Advancing
Precision Therapeutic Delivery
Explore the latest news, announcements, and milestones from Continuity Biosciences as we develop technologies designed to expand treatment possibilities for patients with complex diseases.
In the news
May 20, 2026
Continuity Biosciences Announces First-in-Human Clinical Trial in Pancreatic Cancer
See more
March 26, 2026
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study
See more
June 4, 2025
Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer
See more
November 13, 2024
Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies
See more